DigiCon

Pharyngitis

Acute Maxillary sinusitis

Acute exacerbation of Chronic Bronchitis

Tonsillitis

Community Acquired Pneumonia

Other indication (please mention)

Treatment: (study drug to be given twice daily)

Cepodem XP tablet (200 mg + 125 mg)^$

Cepodem XPDS (50 mg +31.25 mg)^$

Cepodem XPDS (100 mg + 62.5mg)^$

($: Cefpodoxime and clavulanic acid respectively)

Duration of treatment:

5 Days 7 Days 10 Days 14 Days

Symptoms assessment:

Effect on presenting signs and symptoms

Complete resolution of signs and symptoms

Reduction of the majority of the clinical signs and symptoms

Persistence or progression of signs and symptoms of infection

New signs and symptoms

No new signs or symptoms

Development of new clinical findings

Death

Physician’s assessment:

Clinical cure*

Yes No

Clinical improvement **

Yes No

Clinical failure ***

Yes No

* Clinical cure defined as a complete resolution of all acute signs and symptoms of infection, with no new signs or symptoms associated with the original infection.
** Clinical improvement defined as patient who retained evidence of infection but demonstrated a reduction of the majority of the clinical signs and symptoms of infection and no new or worsened signs associated with the original infection
*** Clinical failure defined as any of the following i) persistence or progression of signs and symptoms of infection ii) development of new clinical findings consistent with active infection iii) Death from infection

{{$ActivityTypeName}}

Patient {{$iPatientNo}}

Doctor’s Details

Patient’s Details

Diagnosis

Treatment: (study drug to be given twice daily)

Symptoms assessment:

Effect on presenting signs and symptoms

New signs and symptoms

Physician’s assessment:

Adverse Events